Literature DB >> 28138953

Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.

Luigi Petramala1, Giuseppe Cavallaro2, Matteo Galassi1, Cristiano Marinelli1, Gianfranco Tonnarini1, Antonio Concistrè1, Umberto Costi2, Maurizio Bufi2, Piernatale Lucia1, Giuseppe De Vincentis3, Gino Iannucci1, Giorgio De Toma2, Claudio Letizia4.   

Abstract

INTRODUCTION: This study was designed to evaluate the results of unilateral laparoscopic adrenalectomy in patients with subclinical hypercortisolism (SH) due to adrenal incidentaloma (AI) concerning the main cardiometabolic disorders.
METHODS: We have studied between January 2000 to December 2015, 645 patients with AI (283 males and 362 females; mean age 61.9 ± 10 years) and we found 70 patients with SH (27 males and 43 females; mean age 61.9 ± 8.4 years). Twenty-six (37%) SH patients (6 males and 20 females; mean age 58.7 ± 7.1 years) underwent unilateral laparoscopic adrenalectomy, whereas 44 SH patients (21 males and 23 females; mean age 63.9 ± 9.9 years) performed a conservative treatment. All SH patients were evaluated at diagnosis and after follow-up (mean 12 months; range 9-15 months).
RESULTS: In only SH patients undergoing unilateral adrenalectomy we found a statistical significant reduction of the arterial hypertension and metabolic syndrome (p < 0.05, respectively). In particular we observed a reduction of 24-h systolic blood pressure and "non-dipper" pattern (p < 0.05, respectively) evaluated with ambulatory blood pressure monitoring (ABPM).
CONCLUSIONS: Our study confirm the high prevalence of SH in AI, and the unilateral laparoscopic adrenalectomy seemed to have a beneficial effect on some cardiometabolic disorders.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Cardiometabolic disorders; Subclinical hypercortisolism due to adrenal incidentaloma; Unilateral laparoscopy adrenalectomy

Mesh:

Substances:

Year:  2017        PMID: 28138953     DOI: 10.1007/s40292-017-0182-7

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  27 in total

1.  Scintigraphic diagnosis of subclinical Cushing's syndrome in patients with adrenal incidentalomas.

Authors:  L Dominguez-Gadea; L Diez; G Piedrola-Maroto; A Crespo
Journal:  Nucl Med Commun       Date:  1996-01       Impact factor: 1.690

Review 2.  Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk.

Authors:  Ramón C Hermida; Ana Moyá; Diana E Ayala
Journal:  Endocrinol Nutr       Date:  2015-09-26

Review 3.  Subclinical hypercortisolism in adrenal incidentaloma.

Authors:  Miguel Debono; John Newell-Price
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

4.  Development of overt Cushing's syndrome in patients with adrenal incidentaloma.

Authors:  Luisa Barzon; Francesco Fallo; Nicoletta Sonino; Marco Boscaro
Journal:  Eur J Endocrinol       Date:  2002-01       Impact factor: 6.664

5.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Authors:  Andrea Rebellato; Andrea Grillo; Francesca Dassie; Nicoletta Sonino; Pietro Maffei; Chiara Martini; Agostino Paoletta; Bruno Fabris; Renzo Carretta; Francesco Fallo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

6.  Long-term follow-up study of patients with adrenal incidentalomas.

Authors:  Rossella Libè; Chiara Dall'Asta; Laura Barbetta; Andrea Baccarelli; Paolo Beck-Peccoz; Bruno Ambrosi
Journal:  Eur J Endocrinol       Date:  2002-10       Impact factor: 6.664

7.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

Review 8.  The ubiquitous mineralocorticoid receptor: clinical implications.

Authors:  Urseline A Hawkins; Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

9.  Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases.

Authors:  Michele Ceruti; Luigi Petramala; Dario Cotesta; Sabrina Cerci; Valentina Serra; Chiara Caliumi; Monica Iorio; Giorgio De Toma; Antonio Ciardi; Domenico Vitolo; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

10.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

View more
  10 in total

Review 1.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

2.  Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.

Authors:  Filippo Ceccato; Mattia Barbot; Nora Albiger; Giorgia Antonelli; Marialuisa Zilio; Marco Todeschini; Daniela Regazzo; Mario Plebani; Carmelo Lacognata; Maurizio Iacobone; Franco Mantero; Marco Boscaro; Carla Scaroni
Journal:  Endocrine       Date:  2017-09-27       Impact factor: 3.633

3.  Cardiovascular and metabolic risk factors in patients with subclinical Cushing.

Authors:  Luigi Petramala; Federica Olmati; Antonio Concistrè; Riccardo Russo; Martina Mezzadri; Maurizio Soldini; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  Endocrine       Date:  2020-04-16       Impact factor: 3.633

4.  Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Authors:  Marta Araujo-Castro; César Mínguez Ojeda; María Noelia Sánchez Ramírez; Victoria Gómez Dos Santos; Eider Pascual-Corrrales; María Fernández-Argüeso
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

Review 5.  Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.

Authors:  Alan Kelsall; Ahmed Iqbal; John Newell-Price
Journal:  Gland Surg       Date:  2020-02

6.  Nonfunctioning and Subclinical Cortisol Secreting Adrenal Incidentalomas and their Association with Metabolic Syndrome: A Systematic Review.

Authors:  Uzma Khan
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun

7.  Silent Adrenal Pheochromocytoma Coexistent with Corticomedullary Hyperplasia: A Case Incidentally Discovered.

Authors:  Luigi Petramala; Antonio Concistrè; Federica Olmati; Vincenza Saraceno; Gino Iannucci; Antonio Ciardi; Giorgio De Toma; Claudio Letizia
Journal:  Eur J Case Rep Intern Med       Date:  2017-10-06

8.  Preoperative prognostic nomogram for prophylactic steroid treatment of patients with subclinical Cushing's syndrome.

Authors:  Dengqiang Lin; Jinglai Lin; Xiaoyi Hu; Yujun Liu; Jianping Zhang; Li Zhang; Jingjing Jiang; Xiaomu Li; Jianming Guo
Journal:  Transl Androl Urol       Date:  2021-01

9.  Impact of Adrenalectomy on Morbidity in Patients with Non-Functioning Adrenal Cortical Tumours, Mild Hypercortisolism and Cushing's Syndrome as Assessed by National and Quality Registries.

Authors:  Lo Hallin Thompson; Jonas Ranstam; Martin Almquist; Erik Nordenström; Anders Bergenfelz
Journal:  World J Surg       Date:  2021-06-27       Impact factor: 3.352

Review 10.  Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Authors:  F Ceccato; M Barbot; C Scaroni; M Boscaro
Journal:  J Endocrinol Invest       Date:  2021-06-23       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.